Wed01272021

Last updateWed, 13 Jan 2021 10am

Back You are here: Inicio Biology & biomedicine Technological offers

An amazing enzyme by directed evolution

Scientists at the CSIC have obtained a laccase enzyme which can have very different uses: from fuel cell to oxygen detection, bioremediation or ecological pulp bleaching.

Read more ...

Kit to predict success of lupus nephritis treatment

The CSIC and the Hospital Vall d’Hebron have developed a prognosis method for lupus nephritis based on the quantification of the level of gene expression in urine of Neuropilin 1 gene (NRP1). Companies interested in manufacturing and marketing the prognosis kit based on this technology are sought.

Read more ...

A forum focused on drugs development

The CSIC collaborates with Pharmaprocess, which will take place in Barcelona, from 29-30 October 2013. This global Forum will be focused on the pharmaceutical and biopharma industries. An expositive and ‘networking’ zone will allow visitors to learn first hand some of the current projects and technological offers.

Read more ...

Chimera peptides for early detection of rheumatoid arthritis

Detecting early rheumatoid arthritis is essential in preventing the worst consequences. New ELISA sensors enable a higher sensitivity and specificity than current tests. The sensors are based on synthetic ‘chimera ’ peptides which have, together in a single molecule, regions of several proteins containing the structural changes that happen in rheumatoid arthritis.

Read more ...

Neuroprotective peptides against stroke

Scientists at the CSIC have developed a neuroprotective peptide which can be useful in the treatment and prevention of stroke or cerebral ischemia and other situations that cause brain damage. In vitro experiments have shown its efficacy when used on cultured neurons. Partners interested in licensing the patent are sought.

Read more ...